118 related articles for article (PubMed ID: 1445889)
21. Stabilization of plasmin by lysine derivatives.
Ueshima S; Okada K; Matsuo O
Clin Chim Acta; 1996 Feb; 245(1):7-18. PubMed ID: 8646816
[TBL] [Abstract][Full Text] [Related]
22. Identification of molecular forms of plasminogen and plasmin-inhibitor complexes in urokinase-activated human plasma.
Müllertz S; Thorsen S; Sottrup-Jensen L
Biochem J; 1984 Oct; 223(1):169-77. PubMed ID: 6208893
[TBL] [Abstract][Full Text] [Related]
23. A cyclopeptidic suicide substrate preferentially inactivates urokinase-type plasminogen activator.
Reboud-Ravaux M; Vilain AC; Boggetto N; Maillard J; Favreau C; Xie J; Mazaleyrat JP; Wakselman M
Biochem Biophys Res Commun; 1991 Jul; 178(1):352-9. PubMed ID: 1829886
[TBL] [Abstract][Full Text] [Related]
24. Activation of pro-urokinase and plasminogen on human sarcoma cells: a proteolytic system with surface-bound reactants.
Stephens RW; Pöllänen J; Tapiovaara H; Leung KC; Sim PS; Salonen EM; Rønne E; Behrendt N; Danø K; Vaheri A
J Cell Biol; 1989 May; 108(5):1987-95. PubMed ID: 2523891
[TBL] [Abstract][Full Text] [Related]
25. A monoclonal antibody to the epsilon-aminocaproic acid binding site on the kringle 4 region of human plasminogen that accelerates the activation of Glu1-plasminogen by urokinase.
Cummings HS; Castellino FJ
Arch Biochem Biophys; 1985 Feb; 236(2):612-8. PubMed ID: 2982318
[TBL] [Abstract][Full Text] [Related]
26. Human urokinase and porcine tissue plasminogen activator. A comparative study of the mechanism of fibrinolysis, and the effect of natural proteinase inhibitors and omega-aminocarboxylic acids.
Thorsen S
Dan Med Bull; 1977 Oct; 24(5):189-206. PubMed ID: 908205
[No Abstract] [Full Text] [Related]
27. Conversion of proteolytically modified form (Lys-form) of human plasminogen to plasmin by urokinase in the presence of tranexamic acid.
Takada A; Takada Y
Thromb Res; 1981 Aug 15-Sep 1; 23(4-5):411-9. PubMed ID: 6459659
[No Abstract] [Full Text] [Related]
28. The irreversible inhibition of urokinase, kidney-cell plasminogen activator, plasmin and beta-trypsin by 1-(N-6-amino-n-hexyl)carbamoylimidazole.
Walker B; Elmore DT
Biochem J; 1984 Jul; 221(1):277-80. PubMed ID: 6235806
[TBL] [Abstract][Full Text] [Related]
29. The mechanism of activation of rabbit plasminogen by urokinase. Lack of a preactivation peptide.
Sodetz JM; Brockway WJ; Mann KG; Castellino FJ
Biochem Biophys Res Commun; 1974 Sep; 60(2):729-36. PubMed ID: 4278813
[No Abstract] [Full Text] [Related]
30. The blockage of the high-affinity lysine binding sites of plasminogen by EACA significantly inhibits prourokinase-induced plasminogen activation.
Sun Z; Chen YH; Wang P; Zhang J; Gurewich V; Zhang P; Liu JN
Biochim Biophys Acta; 2002 Apr; 1596(2):182-92. PubMed ID: 12007600
[TBL] [Abstract][Full Text] [Related]
31. Effect of individual caseins on plasminogen activation by bovine urokinase-type and tissue-type plasminogen activators.
Politis I; White JH; Zavizion B; Goldberg JJ; Guo MR; Kindstedt P
J Dairy Sci; 1995 Mar; 78(3):484-90. PubMed ID: 7782505
[TBL] [Abstract][Full Text] [Related]
32. Assembly of urokinase receptor-mediated plasminogen activation complexes involves direct, non-active-site interactions between urokinase and plasminogen.
Ellis V; Whawell SA; Werner F; Deadman JJ
Biochemistry; 1999 Jan; 38(2):651-9. PubMed ID: 9888805
[TBL] [Abstract][Full Text] [Related]
33. The activation mechanism of human plasminogen.
Rickli EE
Thromb Diath Haemorrh; 1975 Nov; 34(2):386-95. PubMed ID: 128150
[No Abstract] [Full Text] [Related]
34. Transformation-dependent activation of urokinase-type plasminogen activator by a plasmin-independent mechanism: involvement of cell surface membranes.
Berkenpas MB; Quigley JP
Proc Natl Acad Sci U S A; 1991 Sep; 88(17):7768-72. PubMed ID: 1652763
[TBL] [Abstract][Full Text] [Related]
35. The structure basis of the poor fibrin specificity of urokinase (II)--The inhibition of urokinase A chain 149-157 on the fibrin stimulated activation of plasminogen by tissue type plasminogen activator.
Song A; Liu JN; Yu RR; Cui DF; Zhou TM; Cui HR; Zhu DX
Sci China B; 1992 Aug; 35(8):966-73. PubMed ID: 1338753
[TBL] [Abstract][Full Text] [Related]
36. Activation of plasminogen to plasmin by a protease associated with the outer membrane of Escherichia coli.
Leytus SP; Bowles LK; Konisky J; Mangel WF
Proc Natl Acad Sci U S A; 1981 Mar; 78(3):1485-9. PubMed ID: 6453346
[TBL] [Abstract][Full Text] [Related]
37. Clot penetration and fibrin binding of amediplase,a chimeric plasminogen activator (K2 tu-PA).
Rijken DC; Barrett-Bergshoeff MM; Jie AF; Criscuoli M; Sakharov DV
Thromb Haemost; 2004 Jan; 91(1):52-60. PubMed ID: 14691568
[TBL] [Abstract][Full Text] [Related]
38. Transport of urokinase across the intestinal tract of normal human subjects with stimulation of synthesis and/or release of urokinase-type proteins.
Toki N; Sumi H; Sasaki K; Boreisha I; Robbins KC
J Clin Invest; 1985 Apr; 75(4):1212-22. PubMed ID: 3921568
[TBL] [Abstract][Full Text] [Related]
39. Control of human plasminogen activation.
Castellino FJ; Urano T; de Serrano V; Morris JP; Chibber BA
Haemostasis; 1988; 18 Suppl 1():15-23. PubMed ID: 3127307
[TBL] [Abstract][Full Text] [Related]
40. The action of antithrombin III on plasmin and activators of plasminogen.
Crawford GP; Ogston D
Biochim Biophys Acta; 1975 May; 391(1):189-92. PubMed ID: 124592
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
